D. Couriel

发表

Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning

Brent Logan, Daniel Couriel, E. Moodie, 2017, American journal of epidemiology.

Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.

T. Braun, B. Storer, Stephanie J. Lee, 2014, Blood.

Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD

D. Marin, E. Shpall, U. Popat, 2021, Bone Marrow Transplantation.

Extracorporeal photopheresis: Focus on therapeutic immunomodulation.

D. Couriel, 2015, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Extracorporeal photopheresis: past, present, and future.

L. French, P. Jaksch, H. Greinix, 2009, Journal of the American Academy of Dermatology.

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

D. Couriel, R. Champlin, M. Duvic, 2003, Bone Marrow Transplantation.

Quantitative Analysis of MR Imaging to Assess Treatment Response for Patients with Multiple Myeloma by Using Dynamic Intensity Entropy Transformation: A Preliminary Study.

Lubomir M. Hadjiiski, Heang-Ping Chan, Jun Wei, 2016, Radiology.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

M. Turner, J. Wingard, Stephanie J. Lee, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

James Ferrara, Peter A Lachenbruch, Daniel Couriel, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prospective computerized monitoring of cognitive functioning before and after blood and marrow transplantation

B. Giordani, D. Couriel, F. Hoodin, 2017, Bone Marrow Transplantation.

Tacrolimus‐associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation

D. Couriel, R. Champlin, A. Forman, 2003, British journal of haematology.

Ancillary and supportive care in chronic graft-versus-host disease.

D. Couriel, 2008, Best practice & research. Clinical haematology.

CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.

D. Couriel, R. Champlin, K. Komanduri, 2004, Blood.

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters.

D. Couriel, O. Khorshid, R. Champlin, 2004, Blood.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

M. Aljurf, J. Szer, R. Gale, 2019, Blood advances.

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

M. Norkin, H. Nakasone, M. Aljurf, 2018, Blood advances.

Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.

M. Aljurf, M. Horowitz, R. Gale, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality

S. Paczesny, D. Couriel, A. Alousi, 2017, Bone Marrow Transplantation.

Transplantation's greatest challenges: advances in chronic graft-versus-host disease.

Stephanie J. Lee, D. Couriel, S. Pavletic, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Colonic graft-versus-host disease

D. Couriel, W. Ross, 2005, Current opinion in gastroenterology.

Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: To Whom, When, and How

D. Couriel, J. Magenau, 2013, Current Oncology Reports.

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation

E. Shpall, U. Popat, M. Qazilbash, 2007, Leukemia.

[18F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility.

R. Fulton, K. Cornetta, J. Dipersio, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Michael J. Ponkowski, E. Kazerooni, B. Ross, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.

E. Shpall, P. Mclaughlin, J. Manning, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cutaneous manifestations of chronic graft-versus-host disease.

M. Turner, D. Couriel, R. Champlin, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

M. Washington, Z. Argényi, A. Rashid, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia

M. Qazilbash, D. Couriel, R. Champlin, 2006, Bone Marrow Transplantation.

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.

K. Cleary, D. Couriel, R. Champlin, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.

G. Hortobagyi, E. Jonasch, D. Booser, 2003, Blood.

A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.

T. Braun, P. Hari, M. Pasquini, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinically Integrated Physical Therapist Practice in Cancer Care: A New Comprehensive Approach.

Christopher A Barnes, C. Ulrich, D. Couriel, 2020, Physical therapy.

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant

M. Munsell, U. Popat, Q. Bashir, 2012, Leukemia & lymphoma.

Central Nervous System Complications of Hematopoietic Stem Cell Transplant.

D. Couriel, A. Srinivasan, D. Frame, 2016, Hematology/oncology clinics of North America.

Phase 1/2 trial of vorinostat plus tacrolimus and mycophenolate to prevent graft versus host disease following related donor reduced intensity conditioning allogeneic hematopoietic stem cell transplantation

J. Dipersio, C. Dinarello, Thomas Braun, 2014 .

Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.

Michael L. Wang, U. Popat, M. Qazilbash, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease.

Allen R. Chen, D. Weisdorf, D. Couriel, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

D. Couriel, R. Champlin, S. Giralt, 2000, Current opinion in oncology.

Tumor necrosis factor-alpha: biological properties

D. Couriel, R. Champlin, S. Giralt, 2022 .

Autologous hematopoietic stem cell therapy in severe systemic sclerosis: ready for clinical practice?

D. Khanna, D. Couriel, G. Georges, 2014, Journal of the American Medical Association (JAMA).

HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE 2014 NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. Pathology Working Group Report

M. Washington, Z. Argényi, A. Rashid, 2006 .

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft‐versus‐host disease

B. Andersson, D. Couriel, R. Champlin, 2005, British journal of haematology.

Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma

M. Kaminski, K. Griffith, S. Jagannath, 2014, Haematologica.

Chronic graft-versus-host disease after allogeneic stem cell transplantation: challenges in prevention, science, and supportive care.

R. Joseph, D. Couriel, K. Komanduri, 2008, The journal of supportive oncology.

Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.

D. Couriel, R. Champlin, K. Komanduri, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: scientific opportunities in extracorporeal photopheresis.

S. Sloan, D. Couriel, N. Dunbar, 2015, Transfusion medicine reviews.

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

E. Shpall, B. Andersson, D. Couriel, 2006, Blood.

Understanding chronic GVHD from different angles.

B. Blazar, D. Couriel, E. White, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.

B. Storer, K. van Besien, Stephanie J. Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison between short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease

B. Storer, Stephanie J. Lee, D. Couriel, 2011 .

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies

E. Shpall, S. Kornblau, M. Qazilbash, 2007, Bone Marrow Transplantation.

High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation

U. Popat, M. Qazilbash, R. Joseph, 2011, American journal of hematology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.

J. Pidala, H. Greinix, V. Bhatt, 2021, Transplantation and cellular therapy.

Biomarkers for Chronic Graft-versus-Host isease : National Institutes of Health Consensus evelopment Project on Criteria for Clinical Trials n Chronic Graft-versus-Host Disease : III . Biomarker orking Group Report

P. Lachenbruch, D. Miklos, E. Holler, 2006 .

ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report

L. Gerber, J. Bolaños-Meade, Stephanie J. Lee, 2006 .

Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation

L. Bashoura, G. Eapen, D. Couriel, 2008, Bone Marrow Transplantation.

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

T. Braun, S. Hanash, J. Ritz, 2013, The New England journal of medicine.

Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

Y. Nieto, V. Bhatt, A. El-Jawahri, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

T. Braun, S. Choi, D. Couriel, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic value of response after upfront therapy for acute GVHD

A. Rashid, D. Couriel, A. Alousi, 2012, Bone Marrow Transplantation.

Bilateral Marginal Keratitis Associated With Engraftment Syndrome After Hematopoietic Stem Cell Transplantation

D. Couriel, Stella K. Kim, E. Dai, 2007, Cornea.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.

S. Hirschfeld, Stephanie J. Lee, M. Flowers, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Endoscopic Biopsy Diagnosis of Acute Gastrointestinal Graft-Versus-Host Disease: Rectosigmoid Biopsies Are More Sensitive Than Upper Gastrointestinal Biopsies

G. Ayers, K. Cleary, Jeffrey H. Lee, 2008, The American Journal of Gastroenterology.

A Phase II Randomized Bayesian Study of Very Low Dose Subcutaneous Decitabine Administered Daily or Weekly Times Three in Patients with Lower Risk Myelodysplastic Syndrome (MDS).

H. Kantarjian, G. Garcia-Manero, A. Nadeem, 2009 .

Non-Myeloablative Allogeneic Stem Cell Transplantation (NMT) Overcomes the Adverse Effects of Treatment Resistance and High Beta-2-Microglobulin in Patients with Mantle Cell Lymphoma (MCL): An Analysis of 123 Transplantations at the MD Anderson Cancer Center.

Michael L. Wang, C. Tam, U. Popat, 2007 .

FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

T. Braun, D. Hanauer, S. Choi, 2015, Bone Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.

U. Popat, M. Qazilbash, D. Couriel, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease

Stephanie J. Lee, S. Paczesny, D. Couriel, 2022, Blood advances.

Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies.

A. Barrett, C. Dunbar, C. Dunbar, 1996, Bone marrow transplantation.

Interaction of natural killer cells with MHC class II: reversal of HLA‐DR1‐mediated protection of K562 transfectant from natural killer cell‐mediated cytolysis by brefeldin‐A

A. Barrett, N. Hensel, D. Couriel, 1996, Immunology.

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease.

H. Deeg, T. Fleming, J. Dipersio, 2007, Blood.

Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes.

J. Pidala, S. Spellman, Tao Wang, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor.

T. Walsh, D. Couriel, C. Gonzalez, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Neurologic Manifestations of Blood Dyscrasias.

D. Couriel, M. Steinbach, Catherine J. Lee, 2016, Hematology/oncology clinics of North America.

A New Measure Of Symptom Burden In Chronic Graft-Versus-Host Disease

C. Cleeland, T. Mendoza, P. McCarthy, 2010 .

Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease.

D. Couriel, K. MacDonald, B. Betts, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease.

D. Couriel, K. MacDonald, B. Betts, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report Transplantation and Cellular Therapy

J. Pidala, H. Greinix, V. Bhatt, 2021 .

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)

K. Griffith, S. Jagannath, A. Jakubowiak, 2011 .

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report Transplantation and Cellular Therapy

Shannon R. McCurdy, R. Jenq, R. Lafyatis, 2021 .

Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study.

D. Berry, J. Wathen, S. Parmar, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tacrolimus in hematopoietic stem cell transplantation

D. Couriel, Kara Fortune, 2009, Expert opinion on drug metabolism & toxicology.

The effect of extracorporeal photopheresis on T cell response in chronic graft-versus-host disease

D. Couriel, Cheong-Hee Chang, Lingqiao Zhu, 2016, Leukemia & lymphoma.

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

T. Braun, S. Hanash, S. Mineishi, 2010 .

Double‐chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units

S. Karandish, D. Couriel, R. Champlin, 2002, British journal of haematology.

Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.

T. Braun, S. Choi, D. Couriel, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation

E. Jabbour, D. Couriel, R. Champlin, 2007, Bone Marrow Transplantation.

B ational Institutes of Health Consensus Development roject on Criteria for Clinical Trials in Chronic raft-versus-Host Disease : I . Diagnosis and Staging orking Group Report

M. Turner, J. Wingard, Stephanie J. Lee, 2005 .

A survey of diagnosis, management, and grading of chronic GVHD.

M. Horowitz, Stephanie J. Lee, M. Flowers, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of extracorporeal photopheresis in chronic graft-versus-host disease.

D. Couriel, V. Radojcic, M. Pletneva, 2015, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Double umbilical cord blood transplantation after novel myeloablative conditioning using a regimen of fludarabine, busulfan, and total lymphoid irradiation.

S. Choi, D. Couriel, G. Yanik, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double Umbilical Cord Blood Transplantation after Novel Myeloablative Conditioning Using FluBu4/TLI

S. Choi, D. Couriel, G. Yanik, 2014 .

Antifungal Treatment in the Blood and Marrow Transplant Setting – Perspectives from Clinical Experience

D. Couriel, 2010 .

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T‐cell lymphoma, nasal type: a CIBMTR analysis

Sonali M. Smith, M. Perales, E. Jacobsen, 2018, British journal of haematology.

An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: A case report

G. Eapen, C. Jimenez, D. Couriel, 2006, BMC Cancer.

Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response

N. Ueno, D. Couriel, R. Champlin, 2004, Bone Marrow Transplantation.

Acute graft‐versus‐host disease: Pathophysiology, clinical manifestations, and management

D. Couriel, R. Champlin, K. Komanduri, 2004, Cancer.

Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis

D. Couriel, C. Kauffman, Anthony J. Perissinotti, 2015, Mycoses.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Shannon R. McCurdy, R. Jenq, G. Cuvelier, 2021, Transplantation and cellular therapy.

Pneumocystis Jirovecii Pneumonia In Recipients Of Autologous Hematopoietic Stem Cell Transplantation: A 10-Year Cohort Study

D. Hanauer, D. Couriel, G. Yanik, 2013 .

Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes

T. Braun, S. Mineishi, S. Choi, 2013, Haematologica.

Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients

T. Braun, D. Couriel, C. Kauffman, 2017, Mycopathologia.

Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant

E. Shpall, Y. Nieto, M. Qazilbash, 2012, Leukemia and Lymphoma.

Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies

E. Shpall, L. Lekakis, D. Couriel, 2006, Bone Marrow Transplantation.

Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.

M. Tallman, R. Gale, M. Flowers, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

P. Thall, E. Shpall, B. Andersson, 2004, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Anita Lawitschka, Stephanie J. Lee, K. Syrjala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

T. Braun, S. Choi, S. Paczesny, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination

D. Couriel, C. Parker, Catherine J. Lee, 2022, Bone Marrow Transplantation.

Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation

D. Couriel, R. Champlin, A. Anagnostopoulos, 2002, Bone Marrow Transplantation.

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.

E. Estey, B. Andersson, P. Cano, 2003, Blood.

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.

M. Munsell, J. Cortes, N. Ueno, 2004, Blood.

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Steven Hirschfeld, Lynn H. Gerber, Sandra A. Mitchell, 2006 .

Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.

P. Thall, B. Andersson, H. Tran, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Musculoskeletal, Neurologic, and Cardiopulmonary Aspects of Physical Rehabilitation in Patients with Chronic Graft-versus-Host Disease.

A. Haig, D. Couriel, Sean R. Smith, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.

E. Shpall, B. Andersson, T. Madden, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.

E. Shpall, D. Couriel, A. Alousi, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series.

T. Braun, S. Mineishi, S. Choi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial.

T. Braun, J. Dipersio, C. Dinarello, 2014, The Lancet Oncology.

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.

M. Kaminski, K. Griffith, S. Jagannath, 2012, Blood.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

P. Thall, E. Shpall, B. Andersson, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

and MDS conditioning regimen for allogeneic stem cell transplantation in AML pharmacokinetic results of a myeloablative, reduced-toxicity Once-daily intravenous busulfan and fludarabine: clinical and

P. Thall, E. Shpall, B. Andersson, 2013 .

Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome

P. Thall, J. D. Cook, E. Shpall, 2008, Leukemia.

Tumor necrosis factor-blockade for the treatment of acute GVHD

B. Andersson, D. Kontoyiannis, D. Couriel, 2004 .

Advances in the treatment of chronic graft‐versus‐host disease

D. Couriel, Eric D. Johnson, 2019, ADVANCES IN CELL AND GENE THERAPY.

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies.

C. Dunbar, D. Couriel, J. Barrett, 1996, Blood.

Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma

U. Popat, M. Qazilbash, D. Couriel, 2007, Bone Marrow Transplantation.

Rituximab‐induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia

M. Qazilbash, D. Couriel, R. Champlin, 2005, American journal of hematology.

Hyperacute GVHD: risk factors, outcomes, and clinical implications.

B. Andersson, M. Qazilbash, D. Couriel, 2007, Blood.

Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

Thomas M Braun, Sophie Paczesny, Takanori Teshima, 2012, Blood.

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

C. Dunbar, D. Couriel, E. Read, 1996 .

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

B. Andersson, D. Kontoyiannis, D. Couriel, 2004, Blood.

Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation.

I. Pastan, A. Barrett, N. Hensel, 1996, Bone marrow transplantation.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.

M. Aljurf, R. Gale, J. Pidala, 2020, Journal of Clinical Oncology.

GVHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes

M. Aljurf, I. Lewis, R. Gale, 2016, Bone Marrow Transplantation.

Steroid-Refractory Acute GVHD: Predictors and Outcomes

E. Shpall, B. Andersson, M. Qazilbash, 2011, Advances in hematology.

Phase II Trial of Vorinostat plus Tacrolimus & Mycophenolate to prevent Graft versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant Blood and Marrow Transplantation Program University of Michigan Comprehensive Cancer Center

T. Braun, S. Choi, D. Couriel, 2012 .

Combination Therapy for GVHD Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial

S. Choi, D. Couriel, G. Yanik, 2016 .

Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission

T. Braun, S. Mineishi, S. Choi, 2015, Annals of Hematology.

Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.

M. Munsell, N. Ueno, B. Andersson, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia

E. Estey, B. Andersson, D. Couriel, 2005, Bone Marrow Transplantation.

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

S. Nikiforow, H. Nakasone, J. Pidala, 2018, Haematologica.

Multifaceted Burden of Chronic Graft-versus-Host Disease.

D. Couriel, V. Radojcic, Catherine J. Lee, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diagnosis and treatment of chronic graft-versus-host disease

D. Couriel, S. Radhakrishnan, 2017 .

Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphoma

J. Griggs, M. Englesbe, Stewart C. Wang, 2015, Leukemia & lymphoma.

Hedgehog blockade in steroid‐refractory sclerotic chronic graft‐versus‐host disease

D. Couriel, V. Radojcic, S. Sarantopoulos, 2021, British journal of haematology.

fludarabine, cyclophosphamide, and rituximab relapsed follicular lymphoma after nonmyeloablative conditioning with Eight-year experience with allogeneic stem cell transplantation for

P. Mclaughlin, N. Ueno, L. Kwak, 2013 .

Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: implications for adoptive immunotherapy with T cells.

A. Barrett, D. Couriel, P. Lewalle, 1996, British journal of haematology.

Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.

P. Thall, J. Wingard, B. Andersson, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.

M. Aljurf, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients Aged 65 Years or Older with AML and MDS.

E. Estey, N. Ueno, D. Couriel, 2004 .

Vaccination with the PR1 Leukemia-Associated Antigen Can Induce Complete Remission in Patients with Myeloid Leukemia.

P. Thall, E. Estey, M. Qazilbash, 2004 .

Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy.

R. Vij, P. McCarthy, B. Logan, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?

E. Shpall, U. Popat, D. Couriel, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Toxicity and Early Response after Intravenous (IV) Busulfan (Bu) Plus Melphalan (Mel) Conditioning for Autologous Stem Cell Transplantation (SCT) in Patients (pts) with Multiple Myeloma (MM).

P. Thall, E. Shpall, B. Andersson, 2006 .

Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.

D. Couriel, R. Champlin, K. Komanduri, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma

D. Couriel, R. Champlin, J. Mcmannis, 2006, Leukemia & lymphoma.

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin’s lymphoma: the updated M.D. Anderson Cancer Center experience

M. Munsell, N. Ueno, B. Andersson, 2008, Haematologica.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

J. Klein, M. Horowitz, J. Wingard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved survival after acute graft-versus-host disease diagnosis in the modern era

Alan M. Miller, R. Vij, W. Wood, 2017, Haematologica.

Cyclosporine in Combination with Mycophenolate Mofetil Leads to Increased Incidence of Graft-Versus-Host Disease and Inferior Outcomes after Myeloablative Allogeneic Hematopoietic Cell Transplantation: A CIBMTR Analysis

Y. Liu, J. Pidala, O. Ringdén, 2018 .

Impact of high-dose chemotherapy on peripheral T-cell lymphomas.

M. Munsell, F. Cabanillas, B. Andersson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trends In Incidence, Presentation, and Outcomes Of Chronic Graft-Versus-Host Disease In Allogeneic Transplantation- Report From The Center For International Blood and Marrow Transplant Research

S. Spellman, Tao Wang, M. Arora, 2013 .

High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

U. Popat, M. Qazilbash, D. Couriel, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Association of Chronic Graft-versus-Host Disease with Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.

R. Gale, J. Pidala, L. Lekakis, 2022, Transplantation and cellular therapy.

Complications of Bone Marrow Transplantation and Immunosuppression

D. Couriel, S. Ghosh, 2005 .

Results of a Phase I/II Study of Gemtuzumab Ozogamicin Added to Fludarabine (F), Melphalan (M) and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed Myeloid Leukemias.

E. Shpall, S. Kornblau, M. Qazilbash, 2005 .

Impact of Cryopreservation on Extracorporeal Photopheresis (ECP)-Treated Leukocyte Subsets.

J. Phillips, D. Couriel, Andrew C. Harris, 2023, Transplantation and cellular therapy.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

J. Kanda, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

hematologic malignancies of hematologic recovery after allogeneic marrow transplants for CD34+ cell dose predicts survival, posttransplant morbidity, and rate

D. Couriel, M. Cottler-Fox, C. Carter, 2011 .

Impact o f H igh-Dose C hemotherapy o n P eripheral T -Cell Lymphomas

M. Munsell, F. Cabanillas, B. Andersson, 2001 .

NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.

J. Bolaños-Meade, Y. Nieto, A. El-Jawahri, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Chronic Graft‐Versus‐Host Disease

D. Couriel, C. Kitko, 2014 .

allogeneic hematopoietic stem cell transplantation syndrome: dose is relevant for long-term disease control after treatment of acute myeloid leukemia and high-risk myelodysplastic Nonablative versus reduced-intensity conditioning regimens in the

M. Munsell, J. Cortes, N. Ueno, 2013 .

26 Reduced early transplant-related mortality following allogeneic stem cell transplantation (SCT) with fludarabine-based, reduced-intensity conditioning from matched related and unrelated donors in advanced Hodgkin's disease (HD)

N. Ueno, B. Andersson, D. Couriel, 2003 .

Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

N. Ueno, D. Couriel, R. Champlin, 2009, International journal of hematology.

Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

M. Norkin, R. Vij, M. Horowitz, 2018, Bone Marrow Transplantation.

Ocular graft vs. host disease experience from MD Anderson Cancer Center: Newly described clinical spectrum and new approach to the management of stage III and IV ocular GVHD

D. Couriel, R. Champlin, Stella K. Kim, 2006 .

Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up.

M. Kaminski, K. Griffith, S. Jagannath, 2013 .

Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.

T. Braun, D. Couriel, G. Yanik, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility.

R. Fulton, K. Cornetta, J. Dipersio, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

15 Sirolimus (rapamycin) for treatment of steroid-refractory chronic graft versus host disease

B. Andersson, D. Couriel, R. Champlin, 2003 .

Tacrolimus in combination with steroids for the treatment of chronic GvHD

D. Couriel, R. Champlin, J. Neuman, 2004 .

Outcomes of Older Patients with Myeloid Leukemias Treated with Myeloablative Intravenous Busulfan-Based Conditioning Regimens and Allogeneic Blood or Marrow Transplantation.

E. Shpall, B. Andersson, D. Couriel, 2005 .

Parametric Response Mapping as a Diagnostic Indicator of Bronchiolitis Obliterans Syndrome

Michael J. Ponkowski, E. Kazerooni, C. Meyer, 2014 .

Pentostatin, Tacrolimus, and “Mini”-Methotrexate for Graft-Versus-Host Disease (GVHD) Prophylaxis: A Phase I/II Controlled, Randomized Study.

E. Shpall, M. Munsell, S. Kornblau, 2004 .

Phase II/III Randomized Study Comparing Two Different Tacrolimus Blood Levels for the Prevention of Graft-Versus-Host Disease (GVHD).

P. Thall, M. Qazilbash, D. Couriel, 2005 .

Hyperacute Graft-Versus-Host Disease: Analysis of Risk Factors, Clinical Manifestations and Outcomes.

E. Shpall, B. Andersson, D. Couriel, 2004 .

Efficacy and Safety of Yttrium 90 (90Y) Ibritumomab Tiuxetan in Autologous and Nonmyeloablative Stem Cell Transplantation (NST) for Relapsed Non-Hodgkin’s Lymphoma (NHL).

D. Podoloff, P. Mclaughlin, N. Ueno, 2006 .

Infectious complications following CAR-t cell therapy for B cell non-Hodgkin lymphoma: a single-center experience and review of the literature

S. Mercadal, D. Couriel, Catherine J. Lee, 2023, Annals of Hematology.

Allogeneic Transplantation after an Alemtuzumab-Containing Myeloablative Conditioning Regimen for CD52 Positive Acute Lymphoblastic Leukemia (ALL).

M. Qazilbash, D. Couriel, R. Champlin, 2005 .

Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML

D. Couriel, R. Champlin, K. Komanduri, 2009, Bone Marrow Transplantation.

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial

A. Nagler, E. Shpall, Richard J. Jones, 2008, Bone Marrow Transplantation.

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

T. Braun, S. Hanash, J. Ritz, 2013, The New England journal of medicine.

Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

T. Braun, S. Choi, D. Couriel, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

M. Horowitz, J. Wingard, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P. Lachenbruch, B. Reeve, S. Hirschfeld, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow allografts have improved Long-term Overall and Graft-versus-Host Disease, Relapse-Free Survival Biol Blood Marrow Transplant.

J. Kanda, J. Pidala, M. Boyiadzis, 2019 .

Access to CAR T-cell therapy: Focus on diversity, equity and inclusion.

D. Couriel, M. S. Odstrcil, Catherine J. Lee, 2023, Blood reviews.

Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study.

D. Berry, S. Parmar, M. Munsell, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Dose Intensification of FluBu2 to FluBu4 on Transplant Related Mortality, Relapse, and Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia in Remission

T. Braun, S. Mineishi, S. Choi, 2013 .

Videokeratoscopic Indices in Chronic Ocular Graft-versus-Host Disease (OGVHD)

D. Couriel, A. Alousi, Stella K. Kim, 2009 .

Surgical Management of Ocular Graft vs. Host Disease

D. Couriel, R. Champlin, Stella K. Kim, 2008 .

Automated identification of spinal cord and vertebras on sagittal MRI

Lubomir M. Hadjiiski, Chuan Zhou, Heang-Ping Chan, 2014, Medical Imaging.

Association of anemia and cognitive dysfunction in patients with acute myelogenous leukemia and myelodysplastic syndrome

U. Popat, M. Qazilbash, R. Joseph, 2011, American journal of hematology.

Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.

D. Couriel, R. Champlin, K. Komanduri, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.